NOTES ON CANCER AND CHEMOTHERAPY EFFICACY
"NCI now actually anticipates further increases, and not decreases, in cancer mortality rates, from 171 in 100,000 in 1984, to 175 in 100,000 by the year 2000!" -Samuel Epstein, The Politics of Cancer, Revisited, 1998
"A study of over 10,000 patients shows clearly that chemo's supposedly strong track record with Hodgkin's disease (lymphoma) is actually a lie. Patients who underwent chemo were 14 times more likely to develop leukemia and 6 times more likely to develop cancers of the bones, joints, and soft tissues than those patients who did not undergo chemotherapy." -NCI Journal, 87:10, John Diamond
Children who are successfully treated for Hodgkin's disease are 18 times more likely to develop secondary malignant tumours later on. Girls face a 35 percent chance of developing breast cancer by the time they are 40, which is 75 times greater than the average. The risk of leukemia increased markedly four years after the ending of successful treatment, and reached a plateau after 14 years, but the risk of developing solid tumours remained high and approached 30 percent at 30 years. -New England Journal of Medicine, March 21, 1996
The New England Journal of Medicine Reports- "The War on Cancer Is a Failure: Despite $30 billion spent on research and treatments since 1970, cancer remains "undefeated" with a death rate not lower but 6% higher in 1997 than 1970." -John C. Bailar III, M.D., Ph.D., and Heather L. Gornik, M.H.S., Department of Health Studies, University of Chicago, Illinois. "The war against cancer is far from over," states Dr. Bailar. "The effect of new treatments for cancer on mortality has been largely disappointing."
"My studies have proved conclusively that untreated cancer victims live up to four times longer than treated individuals. If one has cancer and opts to do nothing at all, he will live longer and feel better than if he undergoes radiation, chemotherapy, or surgery, other than when used in immediate life-threatening situations." -Prof Jones (1956 Transactions of the N.Y. Academy of Medical Sciences, vol. 6). In a fifty page article by Hardin Jones of National Cancer Institute of Bethesda, Maryland, he surveyed global cancer of all types and compared the untreated and the treated, to conclude that the untreated outlived the treated, both in terms of quality and quantity of life.
"With some cancers, notably: liver, lung, pancreas, bone, and advanced breast, our 5 year survival from traditional therapy alone is virtually the same as it was 30 years ago." -P. Quillin, Ph.D.
"A 1.7% increase in terms of success rate a year, it's nothing. By the time we get to the 24th century we might have effective treatments, Star Trek will be long gone by that time." -Ralph Moss
"..chemotherapy's success record is dismal. It can achieve remissions in about 7% of all human cancers; for an additional 15% of cases, survival can be "prolonged" beyond the point at which death would be expected without treatment. This type of survival is not the same as a cure or even restored quality of life." -John Diamond, M.D.
"Keep in mind that the 5 year mark is still used as the official guideline for a "cure" by mainstream oncologists. Statistically, the 5 year mark makes chemotherapy look good for certain kinds of cancer, but when you follow cancer patients beyond 5 years, the reality often shifts in a dramatic way." -Dr. John Diamond, M.D.
"I wouldn't have chemotherapy and radiation because I'm not interested in therapies that cripple the immune system, and, in my opinion, virtually ensure failure for the majority of cancer patients." -Dr. Julian Whitaker, M.D.
"Finding a cure for cancer is absolutely contraindicated by the profits of the cancer industry's chemotherapy, radiation, and surgery cash trough." -Dr. Diamond, M.D.
"We have a multi-billion dollar industry that is killing people, right and left, for financial gain. Their idea of research is to see whether two doses of this poison is better than three doses of that poison." - Glen Warner, M.D., oncologist
Percentage of cancer patients whose lives are predictably saved by chemotherapy - 3%.
Conclusive evidence that chemotherapy has any positive influence on survival or quality of life - none.
Percentage of oncologists who said if they had cancer they would not participate in chemotherapy trials due to their "ineffectiveness and unacceptable toxicity" - 75%.
Percentage of people with cancer in the U.S. who receive chemotherapy - 75%.
Company that accounts for nearly half of the chemotherapy sales in the world - Bristol-Meyers Squibb.
Chairman of the board of Bristol-Meyers Squibb - Richard L. Gelb.
Mr. Gelb's other job: Vice Chairman, Board of Overseers, Board of Managers, Memorial Sloan-Kettering Cancer Center.
Former Chairman, Memorial Sloan-Kettering's Board of Overseers, Board of Managers - John S. Reed.
Reed's other job - Director, Philip Morris (tobacco company).
Director, Ivax, Inc. (chemotherapy company) - Samuel Broder.
Broder's other job (until 1995) - Executive Director, National Cancer Institute.
"If you can shrink the tumour 50% or more for 28 days you have got the FDA's definition of an active drug. That is called a response rate, so you have a response...(but) when you look to see if there is any life prolongation from taking this treatment, what you find is all kinds of hocus pocus and song and dance about the disease free survival, and this and that. In the end there is no proof that chemotherapy in the vast majority of cases actually extends life, and this is the GREAT LIE about chemotherapy, that somehow there is a correlation between shrinking a tumour and extending the life of the patient." -Ralph Moss